ArticleBMC endocrine disorders2026
Impact of vitamin D deficiency on hyperlipidemia and hyperuricemia in pregnant women with gestational diabetes mellitus in Bangladesh.
Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundVitamin D (Vit-D) deficiency is considered a path to metabolic disturbance during pregnancy, especially among women with gestational diabetes mellitus (GDM). This study aimed to investigate the impact of Vit-D status on hyperlipidemia, hyperuricemia, and hypocalcemia in pregnant women with GDM in Bangladesh. MATERIALS AND
methodsSerum biochemical parameters were measured in 335 pregnant women using an automated chemistry and immunoassay analyzer. The associations among these parameters were investigated using the IBM SPSS statistical package. A P value of less than 0.05 was considered statistically significant.
resultsAmong the population, 80.30% and 19.70% were without GDM and GDM, respectively. 30.45%, 48.36%, and 21.19% of the participants were identified as Vit-D sufficient (> 30 ng/mL), insufficient (20-30 ng/mL), and, deficient (< 20 ng/mL) respectively, with a higher prevalence of Vit-D deficiency and insufficiency in the second trimester during pregnancy. Serum Vit-D levels were significantly positively associated with calcium and HDL levels, whereas negative associations were observed with uric acid, fasting blood sugar (FBS), cholesterol (Cho), triglycerides (TG), and LDL (p < 0.05). Remarkably, significantly (P < 0.01) increased levels of uric acid, Cho, TG, LDL, and FBS along with decreased Ca and HDL were observed in the Vit-D-deficient plus GDM group, compared to Vit-D-sufficient plus without GDM group.
conclusionPregnant women with GDM, particularly those with Vit-D deficiency, are significantly associated with a high risk of hyperlipidemia, hyperuricemia, and hypocalcemia. The outcomes of this study emphasize the importance of routine Vit-D screening during pregnancy to minimize the threat of hostile metabolic outcomes during pregnancy and the postpartum period. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.